A gay man is first diagnosed with prostate cancer at age 84. The cancer is aggressive and requires treatment. He struggles with the choice of treatment. Surgery is inadvisable because the cancer has already advanced beyond the capsule, and surgery raises the danger of possible metastasis. ...
Prostate cancer, disease characterized by uncontrolled growth of cells within the prostate gland. Prostate cancer is a frequently diagnosed cancer among males. Learn more about the causes, symptoms, and treatment of prostate cancer.
Treatment guidelines recommend that curative radiation treatment of prostate cancer be offered only to men whose life expectancy is greater than 10 years. The average life expectancy of North American males is less than 10 years after age 75, yet many men older than 75 years receive curative radi...
Several risk factors such as family history, race, obesity, diet and other environmental factors have been associated with prostate cancer. The best established risk factor for prostate cancer is age, whereby there is an estimated incidence of 80% in men by 80 years of age [2]. Hence, ...
Counting all stages of prostate cancer together, 5-year-relative survival rates by age are: Under 49: 96.7% 50-54: 97.8% 55-59: 98.4% 60-64: 98.8% 65-69: 99.6% 70-74: 99.5% 75-79: 98.4% 80 and up: 84.6% Prostate Cancer Survival Rates by Stage ...
making impotence orincontinencemuch less common than in the past. Depending on the man's age and the amount of surgery needed to remove all the cancer, nerve-sparing operations allow many men who were able to get erections before surgery to be able to do so after surgery without the need...
Prostate cancer scarcely occurs among men younger than 40 years, whereas the incidence rises progressively with increasing age, culminating round the age of 80 years (6). In most cases, prostate cancer is diagnosed in men examined because of urinary problems. Suspicion after rectal touch or ...
It takes minimal effort to find out which screenings are recommended at every age, and talk to family members to determine a family history of illnesses. The next step is to make an appointment for an annual physical. For men who develop prostate cancer, those with a family history of the...
Reliable prognostic biomarkers to distinguish indolent from aggressive prostate cancer (PCa) are lacking. Many studies investigated microRNAs (miRs) as PCa prognostic biomarkers, often reporting inconsistent findings. We present a systematic review of th
Nick James, lead author of the commission and a professor at the Institute of Cancer Research in London, said: "As more and more men around the world live to middle and old age, there will be an inevitable rise in the number of prostate cancer cases. ...